XERIS PHARMACEUTICALS INC Long-Term Debt, Maturity, Year Three
XERIS PHARMACEUTICALS INC had Long-Term Debt, Maturity, Year Three of $26.70 million as of 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2020-05-07
- 2020-03-31: Long-Term Debt, Maturity, Year Three $26.70M.
- 2019-12-31: Long-Term Debt, Maturity, Year Three $20.00M.
- 2019-09-30: Long-Term Debt, Maturity, Year Three $20.00M.
- 2019-06-30: Long-Term Debt, Maturity, Year Three $12.00M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2020-03-31 | $26.70M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $20.00M 10-K · filed 2020-03-12 |
| 2019-09-30 | $20.00M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $12.00M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $12.00M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $9.00M 10-K · filed 2019-03-06 |
| 2018-09-30 | $9.00M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $4.68M 10-Q · filed 2018-08-14 |